Science and research discoveries have made gene synthesis possible. While this may have appeared like an impossible endeavor a few years ago, some corporations have made significant investments in this industry and are making tremendous progress.
But do you know which companies are on the cutting edge of this market and what sets them apart? This essay focuses on some courageous businesses still pressing ahead into a scientifically helpful future today. They are as follows:
Biomatik is among one of the best DNA synthesis companies in the market. It initially concentrated on CMC Pharmaceutical, Biochemicals, Enzymes, Gene Synthesis, and Peptide Synthesis services. However, its capabilities have rapidly grown to include ELISA Kits, Protein Production, Antibody Production, Protein Expression services, and Antibody Sequencing Services. Biomatik aims to be a valuable partner in life sciences research and drug development by delivering high-quality research tools and tailored solutions to researchers worldwide.
Over 72,000 custom-made items have been given to Biomatik’s global researchers in life sciences, drug discovery, and catalog products. For your research needs, you can count on Biomatik’s quality goods and services. On Google Scholar, you may browse their Customer Testimonials, Selected Articles, and 3,000+ publications citing their exceptional products and services.
2. Illumina, Inc.
llumina, Inc. provides genomic and genetic analysis products based on sequencing and arrays. Previously, the corporation divided its operations into two segments: Core Illumina and Helix. The company deconsolidated the Helix business segment in April 2019, resulting in a single reportable segment known as Core Illumina. The Core Illumina business category is divided into products and Services and Other Revenue. The company’s Services and Other Revenue division provides whole-genome sequencing, noninvasive prenatal testing (NIPT), product support, and genotyping services. The Services and Other Revenue section is further subdivided into Sequencing and Microarray. The Sequencing sub-segment provides the NGS services.
llumina, Inc. serves government laboratories, genomic research centers, academic institutions, hospitals, commercial molecular diagnostics laboratories, and pharmaceutical and consumer genomics enterprises. The company’s manufacturing and research facilities are in the United States, the United Kingdom, and Singapore. Clinical Laboratory Improvement Amendments (CLIA) certified and College of American Pathologists (CAP) approved laboratories primarily conduct the company’s services. Additionally, the company distributes its products globally through distributors in North America, Europe, Latin America, Asia-Pacific, the Middle East, and Africa.
3. Eurofins Scientific SE (Luxembourg)
Eurofins Scientific S.E. is a life science company that provides analytical testing services to various sectors. Clinical Diagnostics, Environment Testing, Food, Feed Testing, Consumer Product Testing, and Bio-Pharmaceutical Services are the customer’s products and services. The company offers NGS Services as part of its Bio-pharmaceutical Services. The company’s Biopharmaceutical Services are offered to the chemical, pharmaceutical, biotechnology, medical device, and cosmetic industries.
The company is in over 60 countries across Europe, North and South America, Asia-Pacific, the Middle East, and Africa. Among others, the company provides NGS services through its subsidiaries, Diatherix (U.S.), Eurofins Viracor, Inc (U.S.), and Eurofins BioPharma Product Testing Australia Pty Ltd (Australia).
4. Brooks Automation, Inc.
Brooks Automation was formed in 1978 in Chelmsford, Massachusetts. Automation, vacuum, and instrumentation equipment is manufactured for various industries, including semiconductor manufacturing, technology device manufacturing, and life sciences. The company mainly sells four categories of equipment: semiconductor automation and life science systems equipment, gas analysis and vacuum measurement equipment, cryopumps, cryo chillers and compressors, and asset tracking equipment.
Brooks Automation, Inc focuses on handling systems and related technology design and construction. While the company’s primary goal is improving performance and efficiency, automation devices assist atmospheric and vacuum-based processes. They provide vacuum pumps and instrumentation to maintain the consistent pressure of the known process gas. Brooks Life Science Systems also provides automated sample management systems, such as automated blood fractionation, cellular imaging, and consumable parts.
5. THE SHOOTING STAR: TWIST BIOSCIENCES
Twist Biosciences surprised the gene synthesis community. It was established in 2013 and swiftly created a proprietary technology by miniaturizing the oligo production and gene assembly processes. This gave this startup a competitive advantage by improving throughput while cutting costs. After raising more than $250 million, the company went public in 2018, and its market capitalization currently surpasses $1 billion.
The plot twist is preoccupied with gene synthesis. They provide both clonal genes and gene fragments. They also feature short turnaround times and the most competitive costs in the market. For numerous years, they have set the gene synthesis standards many competitors have strived to meet. Twist has been aggressively exploring the burgeoning field of DNA data storage in conjunction with Microsoft.
Twist Biosciences offers a contemporary technological architecture that enables users to place orders swiftly. They are the sole provider of an API.
ProteoGenix is a prominent provider of therapeutic antibody development services. ProteoGenix was founded in 2003 to produce diagnostic assays and biotherapeutics for proteins identified by its inventors. The management team rapidly recognized the importance of high-quality antibodies and proteins in producing biopharma products and entering difficult-to-reach clinic settings.
The company’s proposal of sharing its therapeutic antibody and bespoke test capabilities with the life science community immediately gained traction. Significantly, the company’s primary goal is to predict future biomolecule requirements and construct an appropriate development strategy. This entails offering a wide range of new solutions and technologies.
7. GENEWIZ, Inc. (U.S.)
GENEWIZ, Inc., founded in 1999 and headquartered in New Jersey, USA, is one of the top providers of R&D genomics services. Next-generation sequencing, Sanger sequencing, plasmid DNA preparation, PCR, gene synthesis, oligo synthesis, pre-clinical and clinical synthesis, and other services are available to pharma and biotech businesses. Cancer, infectious illness, biomarkers, agriculture, metagenomics, and antibody discovery are among the research fields served by the company.
Also, GENEWIZ, Inc. provides standard and customized NGS library preparation, sequencing, extraction, and bioinformatics solutions. Most of the company’s products are sold to academic institutions and pharmaceutical and biotech firms. GENEWIZ, Inc. also delivers raw sequence data with adjuvant quality scores, an analysis certificate, and a signed QAU certification.
GENEWIZ, Inc. has offices in the United States, China, Germany, Japan, and the United Kingdom. The National Cancer Institute (NCI) designated the business as the Genome Characterization Center in January 2021 to deliver whole exome sequencing for NCI research projects at its Center for Cancer Genomics for more than three years. Furthermore, the company expanded its CLIA-compliant service offering into next-generation sequencing in October 2018. (NGS). Whole genome sequencing and whole exome sequencing were among the new CLIA-compliant NGS offerings.
There are various companies you may rely on for gene synthesis. By researching, you can find out which group to call if you need help. Anyone looking for gene synthesis services might consider the companies indicated above.